Camena Bioscience
Pre-clinicalgSynth®: TdT-free enzymatic-based DNA synthesis technology for the high-throughput production of synthetic genes any sequence, any length, any complexity.
Founded
2016
Focus
Genetics & Genomics
About
gSynth®: TdT-free enzymatic-based DNA synthesis technology for the high-throughput production of synthetic genes any sequence, any length, any complexity.
Funding History
4Total raised: $53M
Series A$23MMercia VenturesOct 15, 2023
Series A$10MMercia Asset ManagementJan 15, 2023
Seed$10MParkwalk AdvisorsJun 15, 2021
Seed$10MParkwalk AdvisorsMar 15, 2021
Company Info
TypePrivate
Founded2016
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile